5-N-[4-[(2-chloro-4-fluorophenyl)carbamoyl]cyclohexyl]-5-N-propan-2-yl-1H-imidazole-4,5-dicarboxamide
C21H25ClFN5O3 — CID 122672490
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-N-[4-[(2-chloro-4-fluorophenyl)carbamoyl]cyclohexyl]-5-N-propan-2-yl-1H-imidazole-4,5-dicarboxamide
5-N-[4-[(2-chloro-4-fluorophenyl)carbamoyl]cyclohexyl]-5-N-propan-2-yl-1H-imidazole-4,5-dicarboxamide (PubChem CID 122672490) has the molecular formula C21H25ClFN5O3 and a molecular weight of 449.91 g/mol. Its IUPAC name is 5-N-[4-[(2-chloro-4-fluorophenyl)carbamoyl]cyclohexyl]-5-N-propan-2-yl-1H-imidazole-4,5-dicarboxamide.
Molecular Properties
| Compound Name | 5-N-[4-[(2-chloro-4-fluorophenyl)carbamoyl]cyclohexyl]-5-N-propan-2-yl-1H-imidazole-4,5-dicarboxamide |
|---|---|
| PubChem CID | 122672490 |
| Molecular Formula | C21H25ClFN5O3 |
| Molecular Weight | 449.91 g/mol |
| Exact Mass | 449.16 |
| IUPAC Name | 5-N-[4-[(2-chloro-4-fluorophenyl)carbamoyl]cyclohexyl]-5-N-propan-2-yl-1H-imidazole-4,5-dicarboxamide |
| SMILES | CC(C)N(C(=O)c1[nH]cnc1C(N)=O)C1CCC(C(=O)Nc2ccc(F)cc2Cl)CC1 |
| InChI | InChI=1S/C21H25ClFN5O3/c1-11(2)28(21(31)18-17(19(24)29)25-10-26-18)14-6-3-12(4-7-14)20(30)27-16-8-5-13(23)9-15(16)22/h5,8-12,14H,3-4,6-7H2,1-2H3,(H2,24,29)(H,25,26)(H,27,30) |
| InChIKey | BWVQMNYWWMYUNU-UHFFFAOYSA-N |
| XLogP | 3.35 |
| TPSA | 121.18 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.91 |
| LogP ≤ 5 | 3.35 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122672490 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.